Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study.

Richard J Bryant, Daniel D Sjoberg, Andrew J Vickers, Mary C Robinson, Rajeev Kumar, Luke Marsden, Michael Davis, Peter T Scardino, Jenny Donovan, David E Neal, Hans Lilja, Freddie C Hamdy

Research output: Contribution to journalArticlepeer-review

40 Downloads (Pure)

Abstract

Many men with elevated prostate-specific antigen (PSA) levels in serum do not have aggressive prostate cancer and undergo unnecessary biopsy. Retrospective studies using cryopreserved serum suggest that four kallikrein markers can predict biopsy outcome.
Original languageEnglish
Pages (from-to)djv095
JournalJournal of the National Cancer Institute
Volume107
Issue number7
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Cancer and Oncology

Fingerprint

Dive into the research topics of 'Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study.'. Together they form a unique fingerprint.

Cite this